Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients

World Journal of Surgery

Volumn 28, Issue 7, 2004, Pages 680-685

  Kosugi, Shin Ichi ^a   Nishimaki, Tadashi ^a   Kanda, Tatsuo ^a   Nakagawa, Satoru ^a   Ohashi, Manabu ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS;

EID: 4143051417     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-6865-y     Document Type: Article

References (19)

1. Nishimaki T, Suzuki T, Suzuki S, et al. Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J. Am. Coll. Surg. 1998; 186:306-312
2. Munck-Wikland E, Kuylenstierna R, Londholm J, et al. Carcinoembryonic antigen, CA 19-9, and CA 50 in monitoring human squamous cell carcinoma of the esophagus. Anticancer Res. 1990;10:703-708
3. McKnight A, Mannell A, Shperling I. The role of carbohydrate antigen 19-9 as a tumor marker of oesophageal cancer. Br. J. Cancer 1989;60: 249-251
4. Nakamura T, Ide H, Eguchi R, et al. CYFRA 21-1 as a tumor marker for squamous cell carcinoma. Dis. Esophagus 1998;11:35-39
5. Shimada H, Takeda A, Arima M, et al. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer 2000;89:1677-1683
6. Sobin LH, Wittekind Ch. TNM Classification of Malignant Tumours, 5th edition, New York, Wiley-Liss, 1997
7. Nishimaki T, Suzuki T, Tanaka Y, et al. Intramural metastases from thoracic esophageal cancer: local indicators of advanced disease. World J. Surg. 1996;20:32-37
8. Nishimaki T, Tanaka O, Suzuki T, et al. Patterns of lymphatic spread in thoracic esophageal cancer. Cancer 1994;74:4-11
9. Mino-Miyagawa N, Kimura Y, Hamamoto K. Tumor-antigen 4: its immunohistochemical distribution and tissue and serum concentrations in squamous cell carcinoma of the lung and esophagus. Cancer 1990;66: 1505-1512
10. Bates SE. Clinical applications of serum tumor markers. Ann. Intern. Med. 1991;115:623-638
11. Yamamoto K, Oka M, Hayashi H, et al. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 1997;79:1647-1655
12. Kawaguchi H, Ohno S, Miyazaki M, et al. CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences. Cancer 2000;89:1413-1417
13. Brockmann JG, St. Nottberg H, Glodny B, et al. Analysis of serum CYFRA 21-1 concentration in patients with esophageal cancer. Anticancer Res. 2000;20:4899-4904
14. Gion M, Tremolada C, Mione R, et al. Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagus. Tumori 1989;75:489-493
15. Clark GW, Ireland AP, Hagen JA, et al. Carcinoembryonic antigen measurements in the management of esophageal cancer: an indicator of subclinical recurrence. Am. J. Surg. 1995;170:597-600
16. Kim YH, Ajani JA, Ota DM, et al. Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach. Cancer 1995;75:451-456
17. Sanders DS, Wilson CA, Bryant FJ, et al. Classification and localization of carcinoembryonic antigen (CEA) related antigen expression in normal oesophageal squamous mucosa and squamous carcinoma. Gut 1994;35:1022-1025
18. Nishimaki T, Suzuki T, Kanda T, et al. Extended radical esophagectomy for superficially invasive carcinoma of the esophagus. Surgery 1999;125:142-147
19. Nishimaki T, Tanaka O, Ando N, et al. Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann. Thorac. Surg. 1999;68:2059-2064